A-Rod may be in hot water with the Yankees

0 Comments

When the news hit last week that the feds wanted to talk to Alex Rodriguez about Anthony Galea, the Canadian doctor in the cross-hairs of an HGH investigation, A-Rod said “this was about someone else.”  The impression which was created, whether A-Rod intended to create it with those words or not, was that he never received treatment from Galea. For their part, the Yankees said that they knew nothing about A-Rod being treated by Galea and said that they never authorized such a thing.

Which makes this all rather problematic:

A sports doctor at the centre of drug
investigations in Canada and the United States said Monday he treated
Alex Rodriguez after the Yankees slugger had hip surgery last year and
prescribed anti-inflammatories but not human growth hormone . . . “He had a damaged hip. Inflamed. It was damaged,” Galea said in an
interview at his clinic. “He needed anti-inflammatories for his hip. I
was basically helping in the rehab.”

The Yankees are standing by their statement that they never approved such treatment. Which could be a big problem if the treatment is determined to have been necessary as opposed to elective, because a team is supposed to sign off on necessary treatments (see, Beltran, Carlos).

The New York media went bananas last week trying to turn this into a steroids story.  It’s really not, not even as it applies to A-Rod.  It is, however, starting to look like another one of those A-Rod-lives-to-create-PR-headache stories, and the New York media is really good at going bananas over those too. So it looks like a sleepy spring training in Tampa just woke the hell up.

Rays’ Díaz gets $24 million, three-year deal, avoids arbitration

Getty Images
1 Comment

ST. PETERSBURG, Fla. – Tampa Bay Rays infielder Yandy Díaz agreed to a $24 million, three-year contract on Tuesday that avoided a salary arbitration hearing.

Díaz’s agreement could be worth $36 million over four seasons.

The 31-year old will receive $6 million this season, $8 million in 2024 and $10 million for 2025. The 2026 club is $12 million with no buyout. There is a $1 million assignment bonus that would be payable by receiving team.

Díaz has spent parts of six seasons in the majors with Cleveland (2017-18) and Tampa Bay (2019-22). He has a career average of .278 with 39 home runs and 198 RBIs.

Acquired by the Rays in a three-team trade on Dec. 13, 2018, Díaz hit .296 with nine homers and 57 RBIs in 137 games last season, He career highs with 71 runs, 140 hits, 33 doubles, and 78 walks.

Díaz was the third Rays’ arbitration-eligible player to reach a deal.

Reliever Pete Fairbanks agreed Friday to a $12 million, three-year contract that could be worth up to $24.6 million over four seasons. The 29-year-old right-hander was 0-0 with a 1.13 ERA in 24 appearances last year after beginning the season on the 60-day injured list with a right lat strain.

Left-hander Jeffrey Springs also agreed last week to a $31 million, four-year contract that could be worth $65.75 million over five seasons.

The 30-year-old began last season in the bullpen and transitioned to the starting rotation in May and finished 9-5 with a 2.46 ERA in 33 appearances, including 25 starts.

Tampa Bay remains scheduled for hearings with right-handers Jason Adam and Ryan Thompson, left-hander Colin Poche, and outfielder Harold Ramírez.